Bruce F Bell
Examiner (ID: 11075)
Most Active Art Unit | 1741 |
Art Unit(s) | 1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102 |
Total Applications | 2788 |
Issued Applications | 2338 |
Pending Applications | 153 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5986633
[patent_doc_number] => 20110098221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'INHIBITORS OF Akt ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/000220
[patent_app_country] => US
[patent_app_date] => 2009-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13200
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098221.pdf
[firstpage_image] =>[orig_patent_app_number] => 13000220
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000220 | INHIBITORS OF Akt ACTIVITY | Jun 23, 2009 | Abandoned |
Array
(
[id] => 4461152
[patent_doc_number] => 07879889
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-01
[patent_title] => 'Therapeutic use of acylaminothiazole derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/488658
[patent_app_country] => US
[patent_app_date] => 2009-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11811
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/879/07879889.pdf
[firstpage_image] =>[orig_patent_app_number] => 12488658
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/488658 | Therapeutic use of acylaminothiazole derivatives | Jun 21, 2009 | Issued |
Array
(
[id] => 6443735
[patent_doc_number] => 20100144606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'COMBINATION 408'
[patent_app_type] => utility
[patent_app_number] => 12/488027
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 32980
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144606.pdf
[firstpage_image] =>[orig_patent_app_number] => 12488027
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/488027 | COMBINATION 408 | Jun 18, 2009 | Abandoned |
Array
(
[id] => 6617137
[patent_doc_number] => 20100099752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING BICYCLIC TYPE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/486567
[patent_app_country] => US
[patent_app_date] => 2009-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8370
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099752.pdf
[firstpage_image] =>[orig_patent_app_number] => 12486567
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/486567 | PHARMACEUTICAL COMPOSITION CONTAINING BICYCLIC TYPE COMPOUNDS | Jun 16, 2009 | Abandoned |
Array
(
[id] => 6163829
[patent_doc_number] => 20110160463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'PROCESS FOR MAKING SUBSTITUTED 2-AMINO-THIAZOLONES'
[patent_app_type] => utility
[patent_app_number] => 12/999961
[patent_app_country] => US
[patent_app_date] => 2009-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16597
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160463.pdf
[firstpage_image] =>[orig_patent_app_number] => 12999961
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999961 | Process for making substituted 2-amino-thiazolones | Jun 15, 2009 | Issued |
Array
(
[id] => 8630196
[patent_doc_number] => 08362268
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-29
[patent_title] => 'Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria'
[patent_app_type] => utility
[patent_app_number] => 12/995437
[patent_app_country] => US
[patent_app_date] => 2009-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 5194
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12995437
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/995437 | Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria | May 28, 2009 | Issued |
Array
(
[id] => 8896792
[patent_doc_number] => 08476313
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Heteroaryl-containing isoflavones as aromatase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/471751
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 11088
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12471751
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/471751 | Heteroaryl-containing isoflavones as aromatase inhibitors | May 25, 2009 | Issued |
Array
(
[id] => 8201200
[patent_doc_number] => 08188125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-29
[patent_title] => 'Human protein tyrosine phosphatase inhibitors and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/467430
[patent_app_country] => US
[patent_app_date] => 2009-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9910
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/188/08188125.pdf
[firstpage_image] =>[orig_patent_app_number] => 12467430
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/467430 | Human protein tyrosine phosphatase inhibitors and methods of use | May 17, 2009 | Issued |
Array
(
[id] => 6114395
[patent_doc_number] => 20110190508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'PREPARATION OF 1,7\'-DIMETHYL-2\'-PROPYL-2,5\'-BI-1H-BENZIMIDAZOLE'
[patent_app_type] => utility
[patent_app_number] => 12/989522
[patent_app_country] => US
[patent_app_date] => 2009-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1286
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20110190508.pdf
[firstpage_image] =>[orig_patent_app_number] => 12989522
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/989522 | Preparation of 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole | Apr 28, 2009 | Issued |
Array
(
[id] => 8028675
[patent_doc_number] => 08143421
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-27
[patent_title] => 'Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/430547
[patent_app_country] => US
[patent_app_date] => 2009-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21260
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/143/08143421.pdf
[firstpage_image] =>[orig_patent_app_number] => 12430547
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/430547 | Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors | Apr 26, 2009 | Issued |
Array
(
[id] => 5404607
[patent_doc_number] => 20090239921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'METHODS FOR TREATING NEOPLASMS WITH DERIVATIVES OF 4,5,6,7-TETRABROMOBENZIMIDAZOLE'
[patent_app_type] => utility
[patent_app_number] => 12/429359
[patent_app_country] => US
[patent_app_date] => 2009-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4470
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239921.pdf
[firstpage_image] =>[orig_patent_app_number] => 12429359
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/429359 | METHODS FOR TREATING NEOPLASMS WITH DERIVATIVES OF 4,5,6,7-TETRABROMOBENZIMIDAZOLE | Apr 23, 2009 | Abandoned |
Array
(
[id] => 5929889
[patent_doc_number] => 20110039848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'FIVE-MEMBERED RING COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 12/989530
[patent_app_country] => US
[patent_app_date] => 2009-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8278
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039848.pdf
[firstpage_image] =>[orig_patent_app_number] => 12989530
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/989530 | FIVE-MEMBERED RING COMPOUND | Apr 22, 2009 | Abandoned |
Array
(
[id] => 5485838
[patent_doc_number] => 20090275603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'NF- kB Inhibitors And Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/418411
[patent_app_country] => US
[patent_app_date] => 2009-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 29232
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275603.pdf
[firstpage_image] =>[orig_patent_app_number] => 12418411
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/418411 | NF-κB inhibitors and uses thereof | Apr 2, 2009 | Issued |
Array
(
[id] => 4619397
[patent_doc_number] => 07999117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-16
[patent_title] => 'Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/413834
[patent_app_country] => US
[patent_app_date] => 2009-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17729
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/999/07999117.pdf
[firstpage_image] =>[orig_patent_app_number] => 12413834
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/413834 | Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors | Mar 29, 2009 | Issued |
Array
(
[id] => 11232025
[patent_doc_number] => 09459249
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-04
[patent_title] => 'Protein labeling with cyanobenzothiazole conjugates'
[patent_app_type] => utility
[patent_app_number] => 12/383832
[patent_app_country] => US
[patent_app_date] => 2009-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 22019
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12383832
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/383832 | Protein labeling with cyanobenzothiazole conjugates | Mar 25, 2009 | Issued |
Array
(
[id] => 7712840
[patent_doc_number] => 08093394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-10
[patent_title] => 'Derivatives of 5-thioxylopyranose and use of same for treatment'
[patent_app_type] => utility
[patent_app_number] => 12/411783
[patent_app_country] => US
[patent_app_date] => 2009-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30292
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/093/08093394.pdf
[firstpage_image] =>[orig_patent_app_number] => 12411783
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/411783 | Derivatives of 5-thioxylopyranose and use of same for treatment | Mar 25, 2009 | Issued |
Array
(
[id] => 5987318
[patent_doc_number] => 20110098329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'CATALYZED CARBONYLATION IN THE SYNTHESIS OF ANGIOTENSIN II ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/933585
[patent_app_country] => US
[patent_app_date] => 2009-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4218
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098329.pdf
[firstpage_image] =>[orig_patent_app_number] => 12933585
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/933585 | Catalyzed carbonylation in the synthesis of angiotensin II antagonists | Mar 18, 2009 | Issued |
Array
(
[id] => 5944919
[patent_doc_number] => 20110105539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => '2\'-HALOBIPHENYL-4-YL INTERMEDIATES IN THE SYNTHESIS OF ANGIOTENSIN II ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/933617
[patent_app_country] => US
[patent_app_date] => 2009-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6022
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105539.pdf
[firstpage_image] =>[orig_patent_app_number] => 12933617
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/933617 | 2′-halobiphenyl-4-yl intermediates in the synthesis of angiotensin II antagonists | Mar 18, 2009 | Issued |
Array
(
[id] => 6002910
[patent_doc_number] => 20110118208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'Thiazolyl-Dihydro-Indazoles'
[patent_app_type] => utility
[patent_app_number] => 12/921588
[patent_app_country] => US
[patent_app_date] => 2009-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31435
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20110118208.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921588
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921588 | Thiazolyl-Dihydro-Indazoles | Mar 12, 2009 | Abandoned |
Array
(
[id] => 9047019
[patent_doc_number] => 08541573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-24
[patent_title] => 'Substituted sulfonamide compounds'
[patent_app_type] => utility
[patent_app_number] => 12/397771
[patent_app_country] => US
[patent_app_date] => 2009-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31406
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12397771
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/397771 | Substituted sulfonamide compounds | Mar 3, 2009 | Issued |